LUZP2 Activators
LUZP2 Activators encompass a range of compounds that indirectly enhance the functional activity of LUZP2, primarily through their influence on neurodevelopmental pathways and neuronal cytoskeletal organization. Compounds like Retinoic Acid, Brain-Derived Neurotrophic Factor (BDNF), and Insulin-like Growth Factor 1 (IGF-1) play significant roles in this enhancement. Retinoic Acid impacts neural differentiation, indirectly promoting LUZP2's involvement in neuronal migration. BDNF and IGF-1, critical for neuronal growth and development, influence neurodevelopmental pathways that indirectly modulate LUZP2's role in cytoskeletal dynamics. Nerve Growth Factor (NGF) further contributes to LUZP2 activation through its role in neuronal survival and differentiation, impacting neuronal development processes where LUZP2 is involved.
Other activators, including Forskolin, Cyclic AMP (cAMP), and Epidermal Growth Factor (EGF), also play crucial roles. Forskolin and cAMP, by modulating intracellular signaling, affect neuronal differentiation and cytoskeletal organization pathways crucial for LUZP2. EGF, through its stimulation of neuronal cell growth, indirectly influences LUZP2's role in neuronal cytoskeletal organization. Additionally, Platelet-Derived Growth Factor (PDGF) and Transforming Growth Factor Beta (TGF-β) modulate cell growth and differentiation pathways, intersecting with LUZP2's functions in neuronal development. Lithium Chloride and Glycogen Synthase Kinase 3 Beta (GSK-3β) inhibitors like SB-216763 influence neurodevelopmental pathways and cytoskeletal dynamics, indirectly enhancing LUZP2 activity. Sphingosine-1-phosphate (S1P), as a signaling lipid, contributes to this regulation by affecting neuronal survival and differentiation, thereby impacting LUZP2's role in the neuronal cytoskeleton. Collectively, these LUZP2 Activators, through their targeted effects on neuronal development and cytoskeletal organization, facilitate the enhancement of LUZP2-mediated functions in neurodevelopment and neural structure maintenance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid indirectly enhances LUZP2 activity by influencing gene expression patterns during neurodevelopment. This impact on neural differentiation pathways indirectly promotes LUZP2's role in neuronal migration and cytoskeletal organization. | ||||||
L-Buthionine sulfoximine | 83730-53-4 | sc-200824 sc-200824A sc-200824B sc-200824C | 500 mg 1 g 5 g 10 g | $286.00 $442.00 $1532.00 $2975.00 | 26 | |
NGF indirectly enhances LUZP2 activity through its role in neuronal survival and differentiation. NGF's impact on neuronal development pathways indirectly affects LUZP2, which is involved in cytoskeletal dynamics in neurons. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, by increasing cAMP levels, indirectly enhances LUZP2 activity. It influences neuronal signaling pathways related to differentiation and cytoskeletal organization, where LUZP2 plays a role. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP, as a secondary messenger, indirectly enhances LUZP2 activity by affecting intracellular signaling pathways in neurons. These pathways are crucial for neuronal migration and cytoskeletal rearrangements, processes in which LUZP2 is involved. | ||||||
Bis(pinacolato)diboron | 73183-34-3 | sc-252467 sc-252467A | 1 g 5 g | $44.00 $82.00 | ||
PDGF indirectly enhances LUZP2 activity by modulating cell growth and survival signaling pathways, which intersect with neuronal development processes involving LUZP2. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride, by modulating signaling pathways like GSK-3β, indirectly enhances LUZP2 activity. It impacts pathways associated with neurodevelopment and cytoskeletal dynamics, crucial for LUZP2's function. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB-216763 inhibits GSK-3β, indirectly enhancing LUZP2 activity by influencing neurodevelopmental pathways and cytoskeletal organization, where LUZP2 is involved. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P, a signaling lipid, indirectly enhances LUZP2 activity by modulating neuronal survival and differentiation, thus influencing cytoskeletal dynamics where LUZP2 is active. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
TGF-β indirectly enhances LUZP2 activity by modulating cell growth and differentiation pathways, affecting the organization of the neuronal cytoskeleton, a process in which LUZP2 plays a role. | ||||||